![]()
|
|
||||||||
(Received for publication, August 25,
1994; and in revised form, December 22, 1994) B61 was originally described as a novel secreted tumor necrosis
factor-
Volume 270,
Number 10,
Issue of March 10, 1995 pp. 5636-5641
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
-inducible gene product in endothelial cells (Holzman, L.
B., Marks, R. M., and Dixit, V. M.(1990) Mol. Cell. Biol. 10, 5830-5838). It was recently discovered that
soluble recombinant B61 could serve as a ligand for the Eck receptor
protein-tyrosine kinase, a member of the Eph/Eck subfamily of receptor
protein-tyrosine kinases (Bartley, T. D., Hunt, R. W., Welcher, A. A.,
Boyle, W. J., Parker, V. P., Lindberg, R. A., Lu, H. S., Colombero, A.
M., Elliott, R. L., Guthrie, R. A., Holst, P. L., Skrine, J. D., Toso,
R. J., Zhang, M., Fernandez, E., Trail, G., Yarnum, B., Yarden, Y.,
Hunter, T., and Fox, G. M.(1994) Nature 368, 558-560).
We now show that B61 can also exist as a cell surface
glycosylphosphatidylinositol-linked protein that is capable of
activating the Eck receptor protein-tyrosine kinase, the first such
report of a receptor protein-tyrosine kinase ligand that is
glycosylphosphatidylinositol-linked. In addition, the expression
patterns of B61 and Eck during mouse ontogeny were determined by in
situ hybridization. Both were found to be highly expressed in the
developing lung and gut, while Eck was preferentially expressed in the
thymus. Finally, the gene for B61 was localized to a specific position
on mouse chromosome 3 by interspecific backcross analysis.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
F. Irie, M. Okuno, K. Matsumoto, E. B. Pasquale, and Y. Yamaguchi Heparan sulfate regulates ephrin-A3/EphA receptor signaling PNAS, August 26, 2008; 105(34): 12307 - 12312. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Freywald, N. Sharfe, C. DE. Miller, C. Rashotte, and C. M. Roifman EphA Receptors Inhibit Anti-CD3-Induced Apoptosis in Thymocytes J. Immunol., April 1, 2006; 176(7): 4066 - 4074. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ojima, H. Takagi, K. Suzuma, H. Oh, I. Suzuma, H. Ohashi, D. Watanabe, E. Suganami, T. Murakami, M. Kurimoto, et al. EphrinA1 Inhibits Vascular Endothelial Growth Factor-Induced Intracellular Signaling and Suppresses Retinal Neovascularization and Blood-Retinal Barrier Breakdown Am. J. Pathol., January 1, 2006; 168(1): 331 - 339. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wykosky, D. M. Gibo, C. Stanton, and W. Debinski EphA2 as a Novel Molecular Marker and Target in Glioblastoma Multiforme Mol. Cancer Res., October 1, 2005; 3(10): 541 - 551. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Wohlfahrt, C. Karagiannidis, S. Kunzmann, M. M. Epstein, W. Kempf, K. Blaser, and C. B. Schmidt-Weber Ephrin-A1 Suppresses Th2 Cell Activation and Provides a Regulatory Link to Lung Epithelial Cells J. Immunol., January 15, 2004; 172(2): 843 - 850. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Yu, H. Luo, Y. Wu, and J. Wu Mouse EphrinB3 Augments T-cell Signaling and Responses to T-cell Receptor Ligation J. Biol. Chem., November 21, 2003; 278(47): 47209 - 47216. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Yu, H. Luo, Y. Wu, and J. Wu Ephrin B2 Induces T Cell Costimulation J. Immunol., July 1, 2003; 171(1): 106 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Munoz, L. M. Alonso-C., R. Sacedon, T. Crompton, A. Vicente, E. Jimenez, A. Varas, and A. G. Zapata Expression and Function of the Eph A Receptors and Their Ligands Ephrins A in the Rat Thymus J. Immunol., July 1, 2002; 169(1): 177 - 184. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wang, N. Miura, A. Bonelli, P. Mole, N. Carlesso, D. P. Olson, and D. T. Scadden Receptor tyrosine kinase, EphB4 (HTK), accelerates differentiation of select human hematopoietic cells Blood, April 15, 2002; 99(8): 2740 - 2747. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Y. Li, Z. Mi, Y. Feng, C. F. McTiernan, R. Zhou, P. D. Robbins, S. C. Watkins, and A. M. Feldman Differential effects of overexpression of two forms of ephrin-A5 on neonatal rat cardiomyocytes Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2738 - H2746. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Feng, Y. Jiang, P. Meltzer, and P. M. Yen Thyroid Hormone Regulation of Hepatic Genes in Vivo Detected by Complementary DNA Microarray Mol. Endocrinol., July 1, 2000; 14(7): 947 - 955. [Abstract] [Full Text] |
||||
![]() |
H.-C. Aasheim, L. W.M.M. Terstappen, and T. Logtenberg Regulated Expression of the Eph-Related Receptor Tyrosine Kinase Hek11 in Early Human B Lymphopoiesis Blood, November 1, 1997; 90(9): 3613 - 3622. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lackmann, R. J. Mann, L. Kravets, F. M. Smith, T. A. Bucci, K. F. Maxwell, G. J. Howlett, J. E. Olsson, T. Vanden Bos, D. P. Cerretti, et al. Ligand for EPH-related Kinase (LERK) 7 Is the Preferred High Affinity Ligand for the HEK Receptor J. Biol. Chem., June 27, 1997; 272(26): 16521 - 16530. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pandey, H. Duan, and V. M. Dixit Characterization of a Novel Src-like Adapter Protein That Associates with the Eck Receptor Tyrosine Kinase J. Biol. Chem., August 18, 1995; 270(33): 19201 - 19204. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Pandey, H Shao, R. Marks, P. Polverini, and V. Dixit Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alpha-induced angiogenesis Science, April 28, 1995; 268(5210): 567 - 569. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |